Literature DB >> 1330462

Chronic intestinal pseudoobstruction in a patient with heart-lung transplant. Therapeutic effect of leuprolide acetate.

J R Mathias1, G S Baskin, V G Reeves-Darby, M H Clench, L L Smith, J H Calhoon.   

Abstract

After orthotopic heart-lung transplantation and immunosuppression, a patient developed intractable nausea and vomiting in association with chronic cytomegalovirus infection. Chronic intestinal pseudoobstruction was documented by antroduodenal manometric study. The patient was treated with leuprolide acetate with resolution of symptoms and improvement of intestinal motility abnormality. This case demonstrates an association of chronic viral infection with acquired intestinal motor disorders. Gastrointestinal complications that are common after organ transplantation might be due to acquired neuromuscular disease. The potential efficacy of leuprolide in such neuromuscular disorders provides a rationale for diagnostic motility studies in patients with "functional" gastrointestinal disorders.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1330462     DOI： 10.1007/bf01299872

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


  33 in total

1.  Studies of idiopathic intestinal pseudoobstruction. II. Hereditary hollow visceral myopathy: family studies.

Authors:  M D Schuffler; C E Pope
Journal:  Gastroenterology       Date:  1977-08       Impact factor: 22.682

2.  A multivariate analysis of the risk of cytomegalovirus infection in heart transplant recipients.

Authors:  M J Gorensek; R W Stewart; T F Keys; M C McHenry; M Goormastic
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

3.  Gastrointestinal transit: the effect of the menstrual cycle.

Authors:  A Wald; D H Van Thiel; L Hoechstetter; J S Gavaler; K M Egler; R Verm; L Scott; R Lester
Journal:  Gastroenterology       Date:  1981-06       Impact factor: 22.682

Review 4.  Neuromuscular disease of the gastrointestinal tract.

Authors:  S Chokhavatia; S Anuras
Journal:  Am J Med Sci       Date:  1991-03       Impact factor: 2.378

5.  Effects of domperidone in patients with chronic unexplained upper gastrointestinal symptoms: a double-blind, placebo-controlled study.

Authors:  R H Davis; M H Clench; J R Mathias
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

6.  Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids.

Authors:  J M Hofflin; I Potasman; J C Baldwin; P E Oyer; E B Stinson; J S Remington
Journal:  Ann Intern Med       Date:  1987-02       Impact factor: 25.391

7.  Cytomegalovirus infection of the upper gastrointestinal tract following liver transplantation--incidence, location, and severity in cyclosporine- and FK506-treated patients.

Authors:  M Sakr; T Hassanein; J Gavaler; K Abu-Elmagd; J Fung; R Gordon; T Starzl; D Van Thiel
Journal:  Transplantation       Date:  1992-04       Impact factor: 4.939

8.  Leuprolide acetate affects intestinal motility in female rats before and after ovariectomy.

Authors:  R Khanna; R M Browne; A D Heiner; M H Clench; J R Mathias
Journal:  Am J Physiol       Date:  1992-01

Review 9.  Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment.

Authors:  M A Jacobson; J Mills
Journal:  Ann Intern Med       Date:  1988-04       Impact factor: 25.391

10.  Nausea, vomiting, and abdominal pain after Roux-en-Y anastomosis: motility of the jejunal limb.

Authors:  J R Mathias; A Fernandez; C A Sninsky; M H Clench; R H Davis
Journal:  Gastroenterology       Date:  1985-01       Impact factor: 22.682
View more
  15 in total

1.  Chronic Intestinal Pseudo-obstruction.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-06

2.  DNA viruses in the pathogenesis of sporadic chronic idiopathic intestinal pseudo-obstruction.

Authors:  H S Debinski; M A Kamm; I C Talbot; G Khan; H O Kangro; D J Jeffries
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

3.  Small Bowel Dysmotility.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1998-12

4.  Augmented Visceral Perception.

Authors:  William L. Hasler
Journal:  Curr Treat Options Gastroenterol       Date:  2001-08

5.  Effect of leuprolide acetate in patients with functional bowel disease. Long-term follow-up after double-blind, placebo-controlled study.

Authors:  J R Mathias; M H Clench; P H Roberts; V G Reeves-Darby
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

6.  Effect of leuprolide acetate in patients with moderate to severe functional bowel disease. Double-blind, placebo-controlled study.

Authors:  J R Mathias; M H Clench; V G Reeves-Darby; L M Fox; P H Hsu; P H Roberts; L L Smith; N J Stiglich
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

7.  Antibodies against gonadotropin-releasing hormone (GnRH) and destruction of enteric neurons in 3 patients suffering from gastrointestinal dysfunction.

Authors:  Bodil Ohlsson; Eva Ekblad; Béla Veress; Agneta Montgomery; Sabina Janciauskiene
Journal:  BMC Gastroenterol       Date:  2010-05-20       Impact factor: 3.067

8.  Antibodies against gonadotropin-releasing hormone (GnRH) in patients with diabetes mellitus is associated with lower body weight and autonomic neuropathy.

Authors:  Kerstin Berntorp; Anders Frid; Ragnar Alm; Gunilla Nordin Fredrikson; Klas Sjöberg; Bodil Ohlsson
Journal:  BMC Res Notes       Date:  2013-08-17

9.  New insights into the understanding of gastrointestinal dysmotility.

Authors:  Bodil Ohlsson; Sabina Janciauskiene
Journal:  Drug Target Insights       Date:  2007-09-25

10.  Antibodies against gonadotropin-releasing hormone in patients with posterior laryngitis.

Authors:  Hillevi Pendleton; Ragnar Alm; Gunilla Nordin Fredrikson; Bodil Ohlsson
Journal:  Drug Target Insights       Date:  2013-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.